References
Owen, M.R., Doran, E. & Halestrap, A.P. Biochem. J. 348, 607–614 (2000).
Shaw, R.J. et al. Science 310, 1642–1646 (2005).
Foretz, M. et al. J. Clin. Invest. 120, 2355–2369 (2010).
Franciosi, M. et al. PLoS ONE 8, e71583 (2013).
Suissa, S. & Azoulay, L. Diabetes Care 35, 2665–2673 (2012).
Pollak, M. Nat. Rev. Cancer 12, 159–169 (2012).
Pollak, M. J. Clin. Invest. 123, 3693–3700 (2013).
Wallace, D.C. Nat. Rev. Cancer 12, 685–698 (2012).
Zakikhani, M., Dowling, R., Fantus, I.G., Sonenberg, N. & Pollak, M. Cancer Res. 66, 10269–10273 (2006).
Larsson, O. et al. Proc. Natl. Acad. Sci. USA 109, 8977–8982 (2012).
Algire, C. et al. Oncogene 30, 1174–1182 (2011).
Shackelford, D.B. et al. Cancer Cell 23, 143–158 (2013).
Birsoy, K. et al. Nature 508, 108–112 (2014).
Pollak, M. Cancer Cell 23, 263–264 (2013).
Gontier, E. et al. Eur. J. Nucl. Med. Mol. Imaging 35, 95–99 (2008).
Madiraju, A.K. et al. Nature published online, doi:10.1038/nature13270 (21 May 2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pollak, M. Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment. Nat Med 20, 591–593 (2014). https://doi.org/10.1038/nm.3596
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3596
- Springer Nature America, Inc.
This article is cited by
-
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
Investigational New Drugs (2022)
-
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
Translational Medicine Communications (2019)
-
Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
BMC Cancer (2019)
-
Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
Archives of Toxicology (2019)
-
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Nature Reviews Clinical Oncology (2017)